Scientific studies have shown that tirzepatides dual GLP-1 and GIP action makes it more potent than semaglutides single GLP-1 action
Glucagon-like peptide 1 (GLP-1) receptor agonists in experimental Alzheimers disease models: a systematic review and meta-analysis of preclinical studies
Initially approved to control diabetes, the drugs effectiveness at helping people lose weight led to their later approval for that purpose as well
Discontinuation rates due to adverse events remain comparable, but strict adherence to a slow, methodical titration schedule is vital for both compounds
Depending on individual evaluation, Kingdom providers may prescribe treatments that support appetite control, metabolic signaling, or fat utilization
The weight loss effects were discovered as a beneficial side effect, and many doctors now prescribe it off-label for weight management